Epigral Ltd.

Market Capital
₹4,095 Cr.
P/E
14.76
Share Price
₹ 986.2 2.45 (0.25%)

Epigral Ltd.

Quick View
₹ 986.2 2.45 (0.25%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has maintained it ROCE despite making significant capex
Pledge
Promoters have not pledged a significant portion of their holding
Working Capital
Working Capital of the company seems to be under control
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years due to earnings
Current vs Historic Valuation
Company is trading at a discount to 3yr historic valuations
Promoter Holding
Promoter has not sold any shares in the last 90 days
Debt
Company should not have issues servicing its debt
ROE
Latest
33.05%
3yr Average
27.54%
5yr Average
27.78%
Net Profit Margin
Latest
16.14%
3yr Average
14.87%
5yr Average
17.74%
ROCE
Latest
33.02%
3yr Average
26.19%
5yr Average
25.13%
Debt to Equity
Latest
0.82
3yr Average
0.99
5yr Average
0.93
Market Share
0% (as of Mar 22)
Chlor-Alkalis - Market Share
locked Source
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Manufacturing Capacity - Caustic Soda (MTPA)
      Source
    • Manufacturing Capacity - Caustic Potash (MTPA)
      Source
    • Capacity Utilization - Chlor-Alkali (%)
      Source
    • Manufacturing Capacity - Chloromethanes (MTPA)
      Source
    • Capacity Utilization - Chloromethanes (%)
      Source
    • Manufacturing Capacity - Hydrogen Peroxide (MTPA)
      Source
    • Capacity Utilization - Hydrogen Peroxide (%)
      Source
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Epigral Ltd.
    From Commodity to Specialty Chemicals - Meghmani Finechem - Logical Investor
    Corporate Governance Red Flags At Meghmani - Logical Investor
    Value Chain - Meghmani Finechem - Dr Prashanth Mishra
    timeline
    Sign Up for Free